Between pathways and networks lies context: Implications for precision medicine

Ted Laderas, Guanming Wu, Shannon McWeeney

Research output: Contribution to journalArticle

Abstract

Precision medicine, broadly defined as considering individual variability in genes, environment, and lifestyle for each person in disease prevention and selection of suitable medical intervention, shows strong promise in the treatment of cancer. Selecting therapies is complicated by multiple routes to gene dysregulation, which manifest in the individual patient within the many different types of genomic measurements. Additionally, multiple mutations exist in patients, a phenomenon known as oncogenic collaboration, which further complicates the selection of therapy. In this article, we discuss current approaches using biological pathways and networks to unify the many types of OMICs data. We argue that a contextual approach combining cancer pathways and networks could lead to a proper understanding of the biology of this significant disease.

Original languageEnglish (US)
Pages (from-to)253-263
Number of pages11
JournalScience Progress
Volume98
Issue number3
DOIs
StatePublished - Sep 1 2015

Keywords

  • Genomic alterations
  • Networks
  • Pathways
  • Precision medicine
  • Targeted drug therapy

ASJC Scopus subject areas

  • General

Fingerprint Dive into the research topics of 'Between pathways and networks lies context: Implications for precision medicine'. Together they form a unique fingerprint.

  • Cite this